42 related articles for article (PubMed ID: 31288582)
1. Treatment of rheumatoid arthritis with curcumin analog 3,5-bis(arylidene)-4-piperidone.
Li W; Yan W; Liu Y; Hou G; Li C
Future Med Chem; 2023 Nov; 15(22):2051-2064. PubMed ID: 37929594
[TBL] [Abstract][Full Text] [Related]
2. Novel 2-phenyl-4H-chromen derivatives: synthesis and anti-inflammatory activity evaluation
Xiao Y; Yan Y; Du J; Feng X; Zhang F; Han X; Hu Y; Liu X
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2589-2597. PubMed ID: 36128868
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene.
Liu Z; Sun J; Wang X; Cao Z
Exp Ther Med; 2021 Mar; 21(3):257. PubMed ID: 33603864
[TBL] [Abstract][Full Text] [Related]
4. Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2
Sun Y; Zhou YQ; Liu YK; Zhang HQ; Hou GG; Meng QG; Hou Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1631-1640. PubMed ID: 32781863
[TBL] [Abstract][Full Text] [Related]
5. Role of NF-κB in hepatocarcinogenesis and its potential inhibition by dietary antioxidants.
Glauert HP
Curr Cancer Drug Targets; 2012 Nov; 12(9):1160-72. PubMed ID: 22873217
[TBL] [Abstract][Full Text] [Related]
6. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation.
Su CM; Hou GG; Wang CH; Zhang HQ; Yang C; Liu M; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1287-1297. PubMed ID: 31288582
[TBL] [Abstract][Full Text] [Related]
7. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine.
Sun Y; Gao ZF; Yan WB; Yao BR; Xin WY; Wang CH; Meng QG; Hou GG
Eur J Med Chem; 2020 Jul; 198():112366. PubMed ID: 32371335
[TBL] [Abstract][Full Text] [Related]
9. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
10. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation.
Zhou YQ; Sun Y; Luo HL; Gao ZF; Zhang HQ; Meng QG; Bai XY; Hou GG; Hou Y
Eur J Med Chem; 2021 Dec; 225():113796. PubMed ID: 34450496
[TBL] [Abstract][Full Text] [Related]
11. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
Yao BR; Sun Y; Chen SL; Suo HD; Zhang YL; Wei H; Wang CH; Zhao F; Cong W; Xin WY; Hou GG
Eur J Med Chem; 2019 Apr; 167():187-199. PubMed ID: 30771605
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
Zhang L; Chen Q; Hou G; Zhao W; Hou Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):264-271. PubMed ID: 30734613
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
